Abstract
NLRP3 pathway plays a vital role in the pathogenesis of different human cancers but still the regulation of NLRP3 pathway largely unknown. Therefore, we examined the levels of NLRP3 and its downstream components (caspase-1 and IL-1β) and its relationship with histone modifiers in renal cancer pathogenesis. Total 30 cases of clear cell renal cell carcinoma (ccRCC), were studied for NLRP3, caspase-1 and IL-1β expression using real-time PCR, which showed the augmented levels of all the three components of NLRP3 inflammasome pathway in ccRCC. Next, role of the FAD dependent monoamine oxidases (LSD2) and jumonji C (JmjC)-domain-containing, iron-dependent dioxygenases (KDM5A) histone demethylases were evaluated in regulation of NLRP3 inflammasome pathway in-vitro using RCC cell line. It was observed that silencing of KDM5A didn’t alter the levels of neither of the NLRP3 component but inhibition of LSD2 showed significant effect on NLRP3 expression while no change in caspase-1 and IL-1β levels. This study suggests that rather LSD2 not KDM5A lysine demethylase family might be involved in the regulation of NLRP3 inflammasome in cancer cells which could be useful for deciphering the future therapeutic targets for the disease.
References
Guo H, Callaway JB, Ting JP (2015) Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med 21:677–687
Moossavi M, Parsamanesh N, Bahrami A, Atkin SL, Sahebkar A (2018) Role of the NLRP3 inflammasome in cancer. Mol Cancer 17:158
Kumar A, Kumari N, Nallabelli N, Prasad R (2019) Pathogenic and therapeutic role of H3K4 family of methylases and demethylases in cancers. Indian J Clin Biochem 34:123–132
Kumar A, Kumari N, Sharma U, Ram S, Singh SK, Kakkar N et al (2019) Reduction in H3K4me patterns due to aberrant expression of methyltransferases and demethylases in renal cell carcinoma: prognostic and therapeutic implications. Sci Rep 9:8189
Kumar A, Kumari N, Nallabelli N, Sharma U, Rai A, Singh SK et al (2020) Expression profile of H3K4 demethylases with their clinical and pathological correlation in patients with clear cell renal cell carcinoma. Gene 739:144498
Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H et al (1973) In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51:1417–1423
Gouravani M, Khalili N, Razi S, Keshavarz-Fathi M, Khalili N, Rezaei N (2020) The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers. Expert Rev Clin Immunol 16:175–187
Xue Y, Du HD, Tang D, Zhang D, Zhou J, Zhai CW et al (2019) Correlation between the NLRP3 inflammasome and the prognosis of patients with LSCC. Front Oncol 9:588
Tang J, Tu S, Lin G, Guo H, Yan C, Liu Q et al (2020) Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia. J Exp Med 217:e20182091
Xue Y, Enosi Tuipulotu D, Tan WH, Kay C, Man SM (2019) Emerging activators and regulators of inflammasomes and pyroptosis. Trends Immunol 40:1035–1052
Barry R, John SW, Liccardi G, Tenev T, Jaco I, Chen CH et al (2018) SUMO-mediated regulation of NLRP3 modulates inflammasome activity. Nat Commun 9:3001
Yang YT, Wang X, Zhang YY, Yuan WJ (2019) The histone demethylase LSD1 promotes renal inflammation by mediating TLR4 signalling in hepatitis B virus-associated glomerulonephritis. Cell Death Dis 10:278
Acknowledgements
The authors are thankful to Indian Council of Medical Research, New Delhi, India for awarding junior and senior research fellowship (3/1/3/JRF-2013/HRD-071 (10440)). The authors would like to thank Professor Shobha Sehgal and Mr. Surya Prakash Sharma for their informative inputs throughout the study.
Funding
No funding was received for the study.
Author information
Authors and Affiliations
Contributions
RP, SKS and NK directed the study. AK, NK and NN designed and performed experiments. AK, NK, NN, and US analysed and interpreted the data. AK, NN, and US wrote the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethical approval
The study was approved by Institute Ethics Committee (Ref No. NK/1597/Ph.D/10916). This study was conducted in accordance with the Declaration of Helsinki.
Informed consent
Informed consent was taken from each participant before collecting the sample.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kumar, A., Nallabelli, N., Sharma, U. et al. In vitro evidence of NLRP3 inflammasome regulation by histone demethylase LSD2 in renal cancer: a pilot study. Mol Biol Rep 47, 7273–7276 (2020). https://doi.org/10.1007/s11033-020-05692-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-020-05692-0